MediPharm Labs (LABS) Competitors C$0.06 0.00 (0.00%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines LABS vs. TGOD, NINE, SUGR, MDP, WMD, VIR, ZOM, IN, META, and DBShould you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), SugarBud Craft Growers (SUGR), Medexus Pharmaceuticals (MDP), WeedMD (WMD), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), InMed Pharmaceuticals (IN), Meta Growth (META), and Decibel Cannabis (DB). These companies are all part of the "drug manufacturers - specialty & generic" industry. MediPharm Labs vs. Green Organic Dutchman Delta 9 Cannabis SugarBud Craft Growers Medexus Pharmaceuticals WeedMD Viridium Pacific Group Zomedica Pharmaceuticals Corp. (ZOM.V) InMed Pharmaceuticals Meta Growth Decibel Cannabis Green Organic Dutchman (TSE:TGOD) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, risk, earnings, dividends and media sentiment. Does the MarketBeat Community believe in TGOD or LABS? Green Organic Dutchman received 154 more outperform votes than MediPharm Labs when rated by MarketBeat users. Likewise, 85.65% of users gave Green Organic Dutchman an outperform vote while only 65.79% of users gave MediPharm Labs an outperform vote. CompanyUnderperformOutperformGreen Organic DutchmanOutperform Votes17985.65% Underperform Votes3014.35%MediPharm LabsOutperform Votes2565.79% Underperform Votes1334.21% Which has preferable earnings & valuation, TGOD or LABS? MediPharm Labs has higher revenue and earnings than Green Organic Dutchman. MediPharm Labs is trading at a lower price-to-earnings ratio than Green Organic Dutchman, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGreen Organic DutchmanC$31.37M0.00-C$137.58M-C$0.26N/AMediPharm LabsC$37.76M0.71-C$13.31M-C$0.04-1.63 Does the media refer more to TGOD or LABS? In the previous week, MediPharm Labs had 2 more articles in the media than Green Organic Dutchman. MarketBeat recorded 2 mentions for MediPharm Labs and 0 mentions for Green Organic Dutchman. MediPharm Labs' average media sentiment score of 0.16 beat Green Organic Dutchman's score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the news media. Company Overall Sentiment Green Organic Dutchman Neutral MediPharm Labs Neutral Is TGOD or LABS more profitable? Green Organic Dutchman has a net margin of 0.00% compared to MediPharm Labs' net margin of -35.25%. Green Organic Dutchman's return on equity of 0.00% beat MediPharm Labs' return on equity.Company Net Margins Return on Equity Return on Assets Green Organic DutchmanN/A N/A N/A MediPharm Labs -35.25%-24.96%-7.17% Do insiders & institutionals have more ownership in TGOD or LABS? 0.7% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryMediPharm Labs beats Green Organic Dutchman on 7 of the 13 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$26.72MC$1.17BC$5.14BC$6.07BDividend YieldN/A3.04%5.09%5.42%P/E Ratio-1.63131.2390.0526.16Price / Sales0.711,981.001,116.251,332.85Price / Cash1.3010.2543.1082.30Price / Book0.543.084.783.07Net Income-C$13.31MC$152.21MC$120.31MC$295.24M7 Day PerformanceN/A-0.48%-1.92%-2.48%1 Month PerformanceN/A-1.88%13.65%-0.91%1 Year PerformanceN/A98.32%28.34%33.65% MediPharm Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSMediPharm LabsN/AC$0.07flatN/A+8.3%C$26.72MC$37.76M-1.63130News CoverageGap DownTGODGreen Organic DutchmanN/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap UpHigh Trading VolumeNINEDelta 9 CannabisN/AC$1.03+3.0%N/A+0.0%C$89.36MC$12.87M19.07940Gap UpSUGRSugarBud Craft GrowersN/AC$11.50flatN/A+10,172.7%C$78.43MC$575.64M13.8644News CoveragePositive NewsGap UpMDPMedexus PharmaceuticalsN/AC$2.92+0.7%C$5.25+79.8%+34.3%C$71.63MC$108.78M58.0098WMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpVIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap UpZOMZomedica Pharmaceuticals Corp. (ZOM.V)N/AC$0.29-6.6%N/A+0.0%C$36.73MN/A-2.6150Gap DownINInMed PharmaceuticalsN/AC$4.19-1.6%N/AN/AC$33.73MC$574,677.00-2.7712METAMeta GrowthN/AC$0.14flatN/A+0.0%C$33.14MC$60.96M-0.6686,500Gap DownDBDecibel Cannabis1.1877 of 5 starsC$0.07flatC$0.28+304.8%-44.4%C$28.63MC$105.60M-7.0083,000Gap DownHigh Trading Volume Related Companies and Tools Related Companies Green Organic Dutchman Competitors Delta 9 Cannabis Competitors SugarBud Craft Growers Competitors Medexus Pharmaceuticals Competitors WeedMD Competitors Viridium Pacific Group Competitors Zomedica Pharmaceuticals Corp. (ZOM.V) Competitors InMed Pharmaceuticals Competitors Meta Growth Competitors Decibel Cannabis Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:LABS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABS Stock Alerts